Distinctive Membrane Accommodation Traits Underpinning the Neutralization Activity of HIV-1 Antibody against MPER

The membrane-proximal external region (MPER), located in the carboxy-terminal section of HIV's envelope glycoprotein (Env) ectodomain, which is essential for viral entry into host cells, has gained considerable attention as a target for HIV vaccine development due to the exceptional neutralization breadth of antibodies against MPER epitopes. A distinctive feature of broadly neutralizing antibodies (bnAbs) targeting MPER is their requirement to accommodate the viral membrane into the surface of the antigen-binding fragment, or Fab moiety, to optimize antigen recognition. In this study, we sought to elucidate the molecular mechanism behind this interaction and its relevance to the antiviral function of bnAb 10E8. We conducted all-atom molecular dynamics simulations of three systems: (i) Fab 10E8 positioned on the surface of a viral-like lipid bilayer (VL-LB), (ii) Fab 10E8 in complex with an MPER helix anchored to the VL-LB via the Env glycoprotein transmembrane domain (TMD), and (iii) a Fab/MPER-TMD complex similarly embedded in the VL-LB but with a chemically optimized Fab 10E8 variant showing enhanced potency. Comparing these systems enabled us to derive atomic-scale Fab-membrane accommodation profiles pertinent to 10E8's neutralizing function. Our findings support that Fab adaptation to the viral membrane interface following epitope binding is crucial for developing MPER-targeted neutralizing activity. This analysis also provides insights into pathways for strengthening lipid interactions, which may prove valuable in designing MPER-based biologics and vaccines to prevent or treat HIV infection.

Authors

Institutions

Publication Details

Journal
Molecular Pharmaceutics
Published
2025-04-09
DOI
https://doi.org/10.1021/acs.molpharmaceut.4c01341
Citations
1
Primary Topic
HIV Research and Treatment
Type
article
Field-Weighted Citation Impact
1.04

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Distinctive Membrane Accommodation Traits Underpinning the Neutralization Activity of HIV-1 Antibody against MPER

Brian Wiley, Edurne Rujas, Cármen Domene, José L. Nieva et al.
1 citations
Molecular Pharmaceutics
HIV Research and Treatment
1.04
article

Distinctive Membrane Accommodation Traits Underpinning the Neutralization Activity of HIV-1 Antibody against MPER

Brian Wiley, Edurne Rujas, Cármen Domene, José L. Nieva, Sara Insausti
article en
1 citations

Abstract

The membrane-proximal external region (MPER), located in the carboxy-terminal section of HIV's envelope glycoprotein (Env) ectodomain, which is essential for viral entry into host cells, has gained considerable attention as a target for HIV vaccine development due to the exceptional neutralization breadth of antibodies against MPER epitopes. A distinctive feature of broadly neutralizing antibodies (bnAbs) targeting MPER is their requirement to accommodate the viral membrane into the surface of the antigen-binding fragment, or Fab moiety, to optimize antigen recognition. In this study, we sought to elucidate the molecular mechanism behind this interaction and its relevance to the antiviral function of bnAb 10E8. We conducted all-atom molecular dynamics simulations of three systems: (i) Fab 10E8 positioned on the surface of a viral-like lipid bilayer (VL-LB), (ii) Fab 10E8 in complex with an MPER helix anchored to the VL-LB via the Env glycoprotein transmembrane domain (TMD), and (iii) a Fab/MPER-TMD complex similarly embedded in the VL-LB but with a chemically optimized Fab 10E8 variant showing enhanced potency. Comparing these systems enabled us to derive atomic-scale Fab-membrane accommodation profiles pertinent to 10E8's neutralizing function. Our findings support that Fab adaptation to the viral membrane interface following epitope binding is crucial for developing MPER-targeted neutralizing activity. This analysis also provides insights into pathways for strengthening lipid interactions, which may prove valuable in designing MPER-based biologics and vaccines to prevent or treat HIV infection.

Molecular PharmaceuticsVol. 22(5)
Ikerbasque (ES), University of the Basque Country (ES), The Art Institutes (US), Fundación Biofísica Bizkaia (ES), University of Bath (GB)
Ministerio de Ciencia, Innovación y Universidades, Eusko Jaurlaritza, Euskal Herriko Unibertsitatea, Engineering and Physical Sciences Research Council, H2020 Marie Skłodowska-Curie Actions
Openalex Percentile: Top 25%
HIV Research and Treatment
1.04
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.